Acute Cerebral Infarction Following Intravenous Glycoprotein IIb/IIIa Inhibitor for Acute Myocardial Infarction.
Stroke is a rare but serious complication of acute myocardial infarction (AMI). Currently, glycoprotein (GP) IIb/IIIa inhibitor is used in clinical practice for acute coronary syndromes and percutaneous coronary interventions (PCIs). The incidence of stroke in patients receiving GP IIb/IIIa inhibitor during PCIs is very low. We report the case of a 47-year-old man who presented with AMI and suffered an acute cerebral infarction after infusion of a GP IIb/IIIa inhibitor following primary PCI.
Department of Cardiology, Konkuk University School of Medicine, Chungju Hospital, Chungju, Korea.
Woong Gil
WG
Choi
Se Won
SW
Oh
Young Joong
YJ
Kim
Jong Gu
JG
Lim
Yoon Sik
YS
Jo